Corona Virus 2019 (COVID-19) ialah penyakit menular yang berkembang sejak bulan Desember 2019 di Wuhan, ibu kota Provinsi Hubei China, sejak itu virus ini menyebar keseluruh dunia dan menjadi global pandemi. Di Indonesia, pada Juli 2021, dikeluarkanlah surat edaran tentang Pelaksanaan Distribusi Obat dengan Persetujuan Darurat untuk penanganan terapi COVID-19 yaitu; Remdesivir, Favipiravir, Oseltamivir, Immunoglobulin, Ivermectin, Tocilizumab, Azithromycin dan Dexamethasone. Pasien yang ingin membeli obat yang mengindikasikan COVID-19 diwajibkan membawa resep dokter. Analisis resep dilakukan sesuai dengan Surat Edaran (SE), meninjau aspek administratif, aspek farmasetik dan aspek klinis. Hasil penelitian ini dapat disimpulkan bahwa terdapat 11 resep pengobatan COVID-19 pada bulan Juli 2021. Terjadi ketidaklengkapan kajian resep baik secara administrasi, farmasetik, serta aspek klinis. Namun seluruh resep telah memiliki ketepatan indikasi dan dosis.

---

Corona Virus 2019 (COVID-19) is an infectious disease that developed in December 2019 in Wuhan, the capital of China's Hubei Province, since then this virus has spread throughout the world and has become a global pandemic. In Indonesia, in July 2021, a circular letter regarding the Implementation of Drug Distribution with Emergency Approval was issued for the handling of COVID-19 therapy, namely; Remdesivir, Favipiravir, Oseltamivir, Immunoglobulin, Ivermectin, Tocilizumab, Azithromycin, and Dexamethasone. Patients who want to buy drugs that indicate COVID-19 are required to bring a doctor's prescription. Prescription analysis was carried out by the Circular Letter, reviewing administrative aspects, pharmaceutical aspects, and clinical aspects. The results of this study can be concluded that there were 11 prescriptions for COVID-19 treatment in July 2021. There were incomplete prescription studies both administratively, pharmaceutically, and clinically. However, all prescriptions have accurate indications and dosages.

Vitacimin is a lozenge product containing vitamin C, produced by PT Takeda Indonesia. The high demand for Vitamin C products has continued to surge dramatically since the global entry of the COVID-19 pandemic in Indonesia in early 2020. With the increasing market demand for Vitacimin, it is also necessary to analyze and optimize the duties and work of employees (packers) in packaging Vitacimin products. This observation is focused on line 3 secondary packaging using machine vision tools that have optical functions, namely object inspection and inspection and pattern recognition. The machine vision tool used is Camera Vision Baumer, which is currently running on a trial period by placing employees who serve as selectors and back up the Camera Vision function. In this study, it can be concluded that the Camera Vision Baumer tool works well and the selector in charge of performing the back up function of the Camera Vision Baumer task can be switched.